PAVmed (PAVM) Change in Accured Expenses (2015 - 2025)

PAVmed has reported Change in Accured Expenses for 11 years, with the latest figure at -$175000.0 in Q4 2025.

• On a quarterly basis, Change in Accured Expenses fell 127.6% year-over-year to -$175000.0 in Q4 2025; TTM through Dec 2025 was -$38000.0, a 101.96% decrease from a year earlier, with the FY2025 full-year figure at -$38000.0, up 87.5% from the prior year.
• Change in Accured Expenses was -$175000.0 for Q4 2025 at PAVmed, down from -$116000.0 in the prior quarter.
• The five-year high for Change in Accured Expenses was $2.6 million in Q4 2021, with the low at -$1.6 million in Q1 2022.
• Average Change in Accured Expenses over 5 years is $265578.9, with a median of $154000.0 recorded in 2024.
• The sharpest annual moves came in 2021 and 2023: Change in Accured Expenses slumped 970.07% in 2021, then soared 18066.67% in 2023.
• Over 5 years, Change in Accured Expenses stood at $2.6 million in 2021, then sank by 70.57% to $775000.0 in 2022, then jumped by 31.48% to $1.0 million in 2023, then slumped by 37.78% to $634000.0 in 2024, then tumbled by 127.6% to -$175000.0 in 2025.
• The last three Change in Accured Expenses figures came in at -$175000.0 (Q4 2025), -$116000.0 (Q3 2025), and $493000.0 (Q2 2025), per Business Quant data.